# DOXYCYCLINE HYCLATE
> **ANDA209402** · Abbreviated New Drug Application (Generic) · Sponsor: CHANGZHOU PHARM · Approved 2019-10-07
## Drug
- **FDA Application Number:** ANDA209402
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXYCYCLINE HYCLATE
- **Generic name:** DOXYCYCLINE
- **Active ingredients:** DOXYCYCLINE HYCLATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHANGZHOU PHARM
- **Manufacturer:** Cranbury Pharmaceuticals, LLC
- **First approval:** 2019-10-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209402)
---
*AI Analytics · CC0 1.0*